ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
Kiranmai Gumireddy(The Wistar Institute), E. Premkumar Reddy(The Graduate Center, CUNY), Stacey J. Baker(Temple University), Nabisa Papathi(Temple University), R. Boomi Nathan(Temple University), J. G. Holland(Icahn School of Medicine at Mount Sinai), Stephen C. Cosenza(Temple University), M. V. Ramana Reddy(Temple University), Jian‐Dong Jiang(Ningbo University)
Cited by 368
Related Papers
Drugging the 'undruggable' cancer targets
|Nature reviews. Cancer|2017|912
The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis
|Nature Communications|2016|213
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
|Theranostics|2019|185
Loss of Epigenetic Control of <i>Synuclein-γ</i> Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers
|Cancer Research|2005|179
Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine
|Arteriosclerosis Thrombosis and Vascular Biology|2005|171